Geftinat 250mg – Affordable Iressa Alternative for Lung Cancer

Name: Geftinat 250mg
Brand: Gefitinib
SKU: 472
Availability: InStock

Geftinat 250 mg tablet contains the active constituent is Gefitinib, which is given to treat some kind of lung cancer (non-small cell), breast cancer, white blood cells cancer and other kind of cancers. In cancer, cells in the body grow and multiply in a way that is 'out of control'. Chemotherapy medicines work by inhibiting the way cells grow and increase in number. Gefitinib belongs to a group of anti-cancer medicines known as tyrosine kinase inhibitors. These medicines work by blocking chemical messengers which send signals to cells to grow. This stops cancer cells from increasing and spreading.

What is Geftinat 250mg used for?

Geftinat 250mg is a cancer chemotherapy medication. The drug interferes with the growth of cancer cells and slows their (production) growth and spread in the body. Geftinat is used in the treatment of (non-small cell) lung cancer. Geftinat may also be used for purposes other than those listed in this medication guide

How does Geftinat 250mg works?

The medicine is processed with the use of gefitinib and basically belongs to a class of anti-cancer medications known as epidermal growth factor receptor tyrosine kinase inhibitors. Geftinat 250mg is widely prescribed for the treatment of non-small cell lung cancer and sometimes for other kind of cancers to. This medicine effectively blocks the activity of chemicals, which increases the growth of cancer cells.

Precautions

What medications interact with Geftinat 250mg?

Before taking Geftinat 250mg, tell your health care specialist if you are taking any other medicines, especially any of the following:

Phenytoin (Dilantin, Phenytek)
Ketoconazole (Nizoral)
Warafrin (Coumadin)
Rifaprine (Rifadin, Rimactane)
Itraconazole (Sporanox)
A stomach acid reducer such as cimetidine (Tagamet, Tagamet HB), ranitidine(Zantac, Zantac 75), esomeprazole(Nexium), lansoprozole(Prevacid), omeprazole (Prilosec), and others.

You may not be able to take geftinat, or you may require a dosage adjustment or special monitoring by your health care specialist if you are taking any of the medicines listed above.

Many other drugs may interact with gefitinib. Talk to your health care specialist before taking any other prescription or(OTC) over-the-counter medicines, including vitamins, minerals, and herbal products.

When should Geftinat 250mg not be used?

Some medicines are not suitable for people with certain conditions, and sometimes medicines may only be used if additional care is taken. For these reasons, before you start taking Geftinat 250 mg it is important that your health care specialist knows:

If you have allergy to any ingredient of this medication
If you have ever had an allergic reaction to a medicine
If you have a medical family history
If you have an infection or feel particularly unwell.
If you have some kind of problems with the way your liver works, or with the way your kidneys works
If you are pregnant or planning to be
If you are breast-feeding
If you are taking or using any other medicines. This includes any medicines you are taking which are available to buy with or without a prescription, such as herbal and complementary medicines, proteins

Missed dose of Geftinat 250 mg

Take the missed dose as quickly as you remember it. However, if it is less than twelve hours before your next dose, skip the missed dose and continue your standard dosing schedule. Don’t take a double dose to make up for a missed one.

What should Geftinat be stored

Keep the tablets in the original pack until used
Keep all the medicine at room temperature
Store it in a cool and dry place
Keep all the medicine away from the sight of children’s and pets
Away from direct sun light and heat

Dosage Instructions

Side Effects

What are the side effects of Gefitinat?

Gefitinat 250 mg may cause side effects. Tell your health care specialist if any of these symptoms are severe or do not go away:

Acne
Mouth sores
Weakness dry skin
Itching
Rash

Some side effects can be serious. If you experience any of these symptoms, call your health are specialist immediately or get emergency medical treatment:

Loss of appetite
Watery eyes
Eye sensitivity to light
Vision changes
New or worsening shortness of breath, cough, or fever
Severe or ongoing diarrhea
Severe abdominal pain
Eye pain, redness, or irritation
Hives
Blisters or peeling skin
Swelling of the tongue, throat, hands, eyes, face, lips, arms, feet, ankles or lower legs
Pain or discomfort in the right upper stomach area
Nausea
Vomiting
Dark urine
Pale stools
Yellowing of the skin or eyes

Geftinat 250 mg may cause other side effects. Seek for medical attention if you have any odd problems while taking this medication.

How to Use

How should Geftinat be used?

Before you start the treatment, read any printed information you have been given by your health care specialist and the printed manufacturer's handout from inside the pack of tablets. These will give you more information about geftinat and will provide a full list of the side-effects which you may experience from taking it.

Geftinat 250 mg will be prescribed for you by a health specialist care who is experienced in treating your condition. The usual dosage is 1 pill ones in a day. It is important that you take the tablets exactly as you are told to by your prescriber. The directions for taking the tablets will be printed on the label of the pack to remind you, but if you are still unsure about what to do, or if you have any other concerns, you should contact your prescriber or hospital clinic for advice.

Infographics

FAQ

What is Gefitinib and what condition does it treat?

Gefitinib is a targeted cancer therapy classified as an epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor. Geftinat 250mg contains this active ingredient and is prescribed primarily for treating non-small cell lung cancer (NSCLC), particularly in patients whose tumours have specific EGFR gene mutations. This oral anticancer medicine works by blocking abnormal protein signals that cause cancer cells to multiply. Gefitinib is typically used when cancer has spread to other parts of the body or when surgery isn't an option. Your oncologist will test for EGFR mutations before prescribing this targeted lung cancer treatment to ensure it's appropriate for your specific condition.

How does Gefitinib work in the body?

Gefitinib works by targeting and blocking the epidermal growth factor receptor (EGFR) on cancer cells. In non-small cell lung cancer with EGFR mutations, these receptors send continuous growth signals that make tumours spread rapidly. Geftinat 250mg inhibits the tyrosine kinase enzyme attached to these receptors, essentially switching off the growth signals. This targeted approach causes cancer cells to stop dividing and eventually die, while having less impact on normal healthy cells compared to traditional chemotherapy. As a precision oncology medicine, this EGFR inhibitor specifically attacks the molecular pathway driving cancer growth rather than broadly affecting all rapidly dividing cells throughout the body.

How long does Geftinat 250mg take to work?

Geftinat 250mg begins working at the cellular level within hours of your first dose as Gefitinib enters the bloodstream and starts blocking EGFR receptors. However, measurable clinical responses in non-small cell lung cancer typically take several weeks to detect through imaging scans or symptom improvement. Most patients undergo their first response assessment after 6-8 weeks of continuous treatment with this targeted therapy. Some individuals notice breathing improvements or reduced cancer-related symptoms within the first month. Response speed varies based on tumour size, mutation type, and individual metabolism. Your oncologist will monitor progress through regular CT scans and blood tests to evaluate how effectively this EGFR inhibitor is controlling your lung cancer.

When and how should I take Geftinat 250mg?

Take Geftinat 250mg exactly as your oncologist prescribes, typically one tablet daily at the same time each day. This EGFR inhibitor can be taken with or without food, though taking it with food may reduce stomach upset in some patients. Swallow the tablet whole with water—don't crush or split it. If you have difficulty swallowing, you can disperse the tablet in water (non-carbonated) and drink immediately. Consistency matters with this targeted cancer therapy; try setting a daily reminder to maintain steady Gefitinib levels in your body. If you miss a dose and it's more than 12 hours until your next scheduled dose, skip it entirely. Never double up on this prescription lung cancer medicine.

Is Geftinat 250mg safe for long-term use?

Geftinat 250mg is designed for ongoing long-term use in managing non-small cell lung cancer, with many patients taking this EGFR tyrosine kinase inhibitor for months or even years. Clinical studies have tracked patients on continuous Gefitinib therapy for extended periods, demonstrating acceptable safety profiles when properly monitored. Your oncology team will conduct regular liver function tests, lung assessments, and eye examinations to detect any emerging issues early. The targeted nature of this cancer medicine means it generally causes fewer systemic problems than traditional chemotherapy during prolonged treatment. Most side effects remain manageable with supportive care throughout long-term therapy. Treatment continues as long as the medicine effectively controls your lung cancer without unacceptable toxicity.

Can I take Geftinat 250mg with other medicines?

Geftinat 250mg can interact with numerous medications, so your healthcare provider must review your complete medicine list before starting this EGFR inhibitor. Drugs that reduce stomach acid—including antacids, proton pump inhibitors like omeprazole, and H2 blockers like ranitidine—can significantly decrease Gefitinib absorption and effectiveness. Strong CYP3A4 enzyme inducers such as rifampicin, phenytoin, and St John's wort may lower blood levels of this targeted therapy. Conversely, medications like warfarin may have enhanced effects when combined with this lung cancer treatment. Grapefruit juice should be avoided. Always inform all your doctors and pharmacists that you're taking this prescription anticancer medicine to prevent potentially dangerous drug interactions.

How does Geftinat 250mg compare to similar medicines in its class?

Geftinat 250mg belongs to the EGFR tyrosine kinase inhibitor class alongside medicines like erlotinib, afatinib, and osimertinib. While all these targeted therapies block EGFR pathways in non-small cell lung cancer, they differ in specificity and generation. Gefitinib is a first-generation EGFR inhibitor effective against common mutations like exon 19 deletions and L858R point mutations. Newer agents like osimertinib also target resistance mutations such as T790M that sometimes develop during Geftinat treatment. However, As an established, we anticancer medicine offers an excellent balance of efficacy, manageable side effects, and cost-effectiveness for first-line therapy in appropriate patients. Your oncologist selects the optimal EGFR-targeted treatment based on your specific mutation profile and treatment history.

Is the generic Gefitinib as effective as branded versions?

Generic Gefitinib formulations like Geftinat 250mg contain the identical active pharmaceutical ingredient as the original branded product and undergo rigorous bioequivalence testing to ensure comparable effectiveness. Regulatory authorities in the USA, UK, Australia, and Canada require generic cancer medicines to demonstrate that they deliver the same amount of active drug into the bloodstream at the same rate as brand-name versions. Clinical outcomes with this generic EGFR inhibitor match those achieved with branded alternatives in treating non-small cell lung cancer. The primary difference lies in pricing rather than therapeutic performance. Many oncologists confidently prescribe generic tyrosine kinase inhibitors because they offer the same anticancer benefits at significantly lower cost, improving treatment accessibility.

Where can I buy Geftinat 250mg online safely?

You can purchase Geftinat 250mg safely through PremiumRxDrugs, a fully licensed online pharmacy serving patients across the USA, UK, Australia, Canada, and internationally. As a verified platform, we are devoted to sourcing authentic Gefitinib directly from approved manufacturers, ensuring you receive genuine targeted cancer therapy rather than counterfeit products. PremiumRxDrugs requires a valid prescription from your oncologist for this EGFR inhibitor to protect patient safety and ensure regulatory compliance. We offer discreet packaging and worldwide shipping options, including free delivery programmes on qualifying orders. With competitive pricing on both generic and branded lung cancer medicines, secure ordering systems, and prescription management tools, PremiumRxDrugs provides a trusted solution for obtaining this essential anticancer medication conveniently.

Why do patients choose PremiumRxDrugs for Geftinat 250mg?

Patients select PremiumRxDrugs for their Geftinat 250mg prescriptions because As an established, we online pharmacy combines affordability with reliability for critical cancer medications. With over a decade of serving international patients, we have built trust through consistently delivering manufacturer-sourced, authentic Gefitinib and other EGFR inhibitors. Competitive pricing makes this lung cancer treatment more accessible without compromising quality. Our discreet packaging respects patient privacy during ongoing cancer therapy, while worldwide shipping with free delivery options ensures uninterrupted access to this essential tyrosine kinase inhibitor. Easy prescription refill management helps patients maintain consistent treatment schedules. Licensed to operate across multiple countries, including the USA, UK, Australia, and Canada, PremiumRxDrugs meets rigorous pharmaceutical standards while offering convenience and cost savings.

What are the common side effects of Gefitinib?

Gefitinib commonly causes skin reactions including acne-like rash, dry skin, and itching, affecting up to 75% of patients taking this EGFR inhibitor—these skin changes often indicate the medicine is working. Diarrhoea occurs frequently and can usually be managed with anti-diarrhoeal medications and dietary adjustments. Many people experience reduced appetite, nausea, and fatigue during treatment with this targeted lung cancer therapy. Eye problems such as dry eyes or conjunctivitis develop in some patients. Nail changes and mouth sores may appear during ongoing therapy. Serious but less common effects include interstitial lung disease (causing new breathing difficulties), liver problems, and gastrointestinal perforation. Most side effects of this tyrosine kinase inhibitor are manageable with supportive care and monitoring.

Who should avoid taking Gefitinib?

Gefitinib should be avoided by individuals with known severe hypersensitivity to this EGFR tyrosine kinase inhibitor or its ingredients. Pregnant women must not use this targeted cancer therapy as it can cause serious foetal harm; effective contraception is essential during treatment and for several weeks afterward. Breastfeeding mothers should avoid this medicine as it may pass into breast milk and affect nursing infants. Patients with severe liver impairment require careful evaluation before starting this lung cancer treatment. Those with pre-existing severe interstitial lung disease or pulmonary fibrosis face increased risk of breathing complications. People who cannot swallow tablets or lack EGFR mutations in their non-small cell lung cancer tumours are generally not suitable candidates for this medication, as effectiveness depends on specific genetic markers.

SKU	472
Generic For	Gefitinib
Strength	250mg
Active Ingredient	Gefitinib

Geftinat 250mg